Concepts (578)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with JEFFREY J MOLLDREM's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that JEFFREY J MOLLDREM has written about over time.
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, MyeloidT-LymphocytesCytotoxicity, ImmunologicPeptide FragmentsMyeloblastinLeukemiaGraft vs Host DiseaseImmunotherapy, AdoptiveT-Lymphocytes, CytotoxicHematopoietic Stem Cell TransplantationAntigens, NeoplasmCancer VaccinesHLA-A2 AntigenPeptidesFetal BloodLeukemia, Myeloid, AcuteLeukocyte ElastaseEpitopes, T-LymphocyteCross-Priming
To see the data from this visualization as text,
click here.
Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 20 | 1996 | 2018 | November 2003 |
Leukemia, Myeloid | 6 | 1996 | 2016 | May 2005 |
T-Lymphocytes | 29 | 1997 | 2023 | November 2006 |
Cytotoxicity, Immunologic | 14 | 1996 | 2019 | November 2007 |
Peptide Fragments | 9 | 1997 | 2018 | January 2008 |
Myeloblastin | 15 | 1996 | 2018 | August 2008 |
Leukemia | 8 | 1998 | 2020 | September 2008 |
Graft vs Host Disease | 28 | 1997 | 2023 | September 2008 |
Immunotherapy, Adoptive | 14 | 1996 | 2019 | March 2009 |
T-Lymphocytes, Cytotoxic | 27 | 1996 | 2021 | June 2010 |
Hematopoietic Stem Cell Transplantation | 28 | 1999 | 2023 | June 2010 |
Antigens, Neoplasm | 17 | 1999 | 2020 | August 2010 |
Cancer Vaccines | 12 | 2001 | 2020 | October 2010 |
HLA-A2 Antigen | 18 | 1996 | 2021 | February 2012 |
Peptides | 13 | 1998 | 2021 | April 2012 |
Fetal Blood | 7 | 2006 | 2016 | November 2012 |
Leukemia, Myeloid, Acute | 22 | 1997 | 2024 | October 2013 |
Leukocyte Elastase | 7 | 2011 | 2017 | February 2014 |
Epitopes, T-Lymphocyte | 7 | 2011 | 2020 | September 2014 |
Cross-Priming | 4 | 2012 | 2018 | March 2015 |
To return to the timeline,
click here.